Alphamab Oncology (FRA:3NK)
Germany · Delayed Price · Currency is EUR 1.170
+0.040 (3.54%)
At close: Nov 27, 2025
Alphamab Oncology Revenue
Alphamab Oncology had revenue of 319.44M CNY in the half year ending June 30, 2025, with 134.08% growth. This brings the company's revenue in the last twelve months to 785.96M, up 207.17% year-over-year. In the year 2024, Alphamab Oncology had annual revenue of 640.08M with 192.58% growth.
Revenue (ttm)
785.96M CNY
Revenue Growth
+207.17%
P/S Ratio
11.97
Revenue / Employee
1.87M CNY
Employees
420
Market Cap
1.12B EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 640.08M | 421.31M | 192.58% |
| Dec 31, 2023 | 218.77M | 51.93M | 31.12% |
| Dec 31, 2022 | 166.85M | 20.82M | 14.26% |
| Dec 31, 2021 | 146.02M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |